Format

Send to

Choose Destination
Autoimmun Rev. 2017 Oct;16(10):999-1007. doi: 10.1016/j.autrev.2017.07.016. Epub 2017 Aug 2.

How I treat idiopathic patients with inflammatory myopathies in the clinical practice.

Author information

1
Department of Rheumatology, IRCCS Policlinico S. Matteo Foundation, University of Pavia, 27100 Pavia, Italy. Electronic address: lorenzo.cavagna@unipv.it.
2
Department of Rheumatology, IRCCS Policlinico S. Matteo Foundation, University of Pavia, 27100 Pavia, Italy.
3
Rheumatology Unit, Department of Medicine, University of Padova, Italy.

Abstract

Management of patients with idiopathic inflammatory myopathies (IIMs) is challenging given the systemic nature of the disease, which is often complicated by potentially life-threatening manifestations and the lack of standardized treatment regimens. Aim of this review is to provide the currently available evidence for immunotherapy in the treatment of various manifestations of IIM in order to help clinicians in the daily management of these patients.

KEYWORDS:

Antisynthetase syndrome; Glucocorticoids; Idiopathic inflammatory myopathies; Immunosuppressants; Therapy

PMID:
28778704
DOI:
10.1016/j.autrev.2017.07.016
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center